Flavivirus and Alphavirus ReVAMPP (FLARE) — Michael S Diamond (WASHINGTON UNIVERSITY)
SUMMARY. The Flavivirus and Alphavirus ReVAMPP (FLARE) Center will develop and optimize protein nanoparticle, virion-based, and mRNA vaccine platforms, and monoclonal antibody (mAb)-based treatments t
| Project title | Flavivirus and Alphavirus ReVAMPP (FLARE) |
|---|---|
| Project number | 1U19AI181960-01 |
| PI name | Michael S Diamond |
| Institution | WASHINGTON UNIVERSITY |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $46.72M |
| Fiscal year | 2024 |
| Project start | 2024-08-12T00:00:00 |
| Project end | 2027-07-31T00:00:00 |
| Abstract | SUMMARY. The Flavivirus and Alphavirus ReVAMPP (FLARE) Center will develop and optimize protein nanoparticle, virion-based, and mRNA vaccine platforms, and monoclonal antibody (mAb)-based treatments t |
| Key terms | <AI system><Ab-mediated immunity><Ab-mediated protection><Address><Ally><Alpha Virus><Animal Disease |
$799/mo
Try GrantRadar →